A parallelized imaging platform for accurate and efficient long-term assessment of brain organoid development - significance: high-content microscopy is rapidly accelerating biological research and…
Active Grant Awarded
- Award ID
- R44MH133521
- Recipient
-
Ramona Optics Inc. UEI MR4ZCJJQHHP5
- Awarding agency
-
National Institute of Mental Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $745,337
Award facts
- Assistance listing
- 93.242 Mental Health Research Grants
- Completion date 7% complete
- Place of performance
- Durham, NC 27701, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health, awarded Ramona Optics Inc. a grant obligating $745,337 on September 4, 2026, under the Mental Health Research Grants program (CFDA 93.242). The award runs through an ultimate completion date of August 31, 2029, with place of performance in Durham, North Carolina.
The award funds a Phase II effort to build a parallelized imaging platform for high-content 3D assessment of organoid cultures, with a focus on brain organoids. Subaward 1 covers production of 48 parallelized microscopes for 4-channel fluorescence and bright-field video capture. Each microscope carries a 20 MP sensor, yielding 960 MP per snapshot at 30 Hz video, with both 4X and 10X-equivalent optics. Performance will be quantified in a first screen of 288 cortical organoids expressing GCaMP8. Subaward 2 covers rapid 3D processing and activity measurement software. The effort is designed to produce a productized system, PF-3D, for subsequent sale.
Description
A parallelized imaging platform for accurate and efficient long-term assessment of brain organoid development - significance: high-content microscopy is rapidly accelerating biological research and drug development. Unfortunately, existing imaging systems fail to efficiently image three-dimensional disease models, such as organoid cultures, at the throughput required by clinical and commercial researchers. With an increasing desire to record time-lapse live cell dynamics across multiple fluorescence channels, faster imaging and software is required. One of the primary drawbacks of standard microscopes is their need to step-and-scan across a well plate, which can take minutes to image all wells in two dimensions, and an hour or more for 3D capture. This not only leads to cumbersome experiments but also prevents high-content measurement of live dynamics like the fluorescent neural activity within cortical organoids. Proposal: ramona optics has developed a new imaging platform for rapid high-content 3D screening of 3D organoid cultures. Phase I efforts showcased daily 3D imaging of nearly 10,000 unique patient- derived cortical organoid specimens across 3 months for unique insights into growth dynamics. In this phase II effort, we aim to integrate multi-channel EPI-illumination fluorescence video capture and create parallelized software for rapid registration and assessment of live-cell functional organoid activity and network analysis. These achievements will result in a productized system (PF-3D) for subsequent sale. SA1: hardware for parallelized 3D EPI-fluorescence: ramona optics will produce new parallelized microscope hardware for 4-channel fluorescence and bright-field video capture with 48 parallelized microscopes (20 MP each, 960 MP/snapshot, 30 HZ video) with both 4X and 10X-equivalent optics. We will quantify performance within a first screen of 288 cortical organoids expressing GCAMP8. SA2: rapid 3D processing and activity measurement software: we will produce software to rapidly synthesize 4-channel 3D fluorescence imagery (2X. SA4: high-content screen measuring brain organoid network activity: with the stein lab at UNC, we will complete a first-of-its-kind high-content drug screen using cortical organoids developed from 50 clinical participants (6000 specimens total) where live-cell network activity is used as the live-cell readout. We will examine the longitudinal impact of neurotransmitters and drugs on spontaneous firing and neuronal network formation, using gold-standard microscopy and multi-electrode arrays for verification, to help establish how individuals respond differently to treatments depending upon their genotypes.
Quick answers
Who received award R44MH133521?
R44MH133521 was awarded to Ramona Optics Inc. by National Institute of Mental Health (National Institutes of Health) on September 4, 2026.
How much is award R44MH133521 worth?
$745,337 has been obligated on R44MH133521.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award